HC Wainwright reaffirmed their buy rating on shares of Exelixis (NASDAQ:EXEL – Free Report) in a research note issued to investors on Thursday,Benzinga reports. HC Wainwright currently has a $40.00 ...

Exelixis, Inc. today announced that the company's Board of Directors has authorized the repurchase of up to an additional $500 million of the company's common stock before December 31, 2025. Exelixis ...

Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the fourth quarter and fiscal year of 2024, provided an update on progress toward achieving key ...

At the same time, Entain Plc (ENT.LN) tumbled more than -10% after the British ... In corporate news, SAIC Motor climbed over +4% after a mainland media outlet reported that the company set up a new ...

The company said, “there are no mass layoffs. We remain in close coordination with Exel-Tech on the transition ... acquisition of CCEAP by Coca-Cola Europacific Partners Plc and Aboitiz Equity ...

In a report released today, Peter Lawson from Barclays maintained a Hold rating on Exelixis (EXEL – Research Report), with a price target of ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Scilex Holding Company (SCLX – Research Report) and Exelixis (EXEL – Research Report ...

Many value investors pay close attention to a company's earnings as well. For EXEL, four analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has ...

Exelixis Inc (NASDAQ:EXEL) reported strong financial performance with a 20% year-over-year growth in US cabo franchise net product revenues for Q4 2024. The company is advancing its oncology ...